WEST MICHAEL D 4
4 · AgeX Therapeutics, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
WEST MICHAEL D
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2021-12-11+3,125→ 39,652 total - Exercise/Conversion
Restricted Stock Units
2021-12-11−3,125→ 15,625 totalExercise: $0.00→ Common Stock (3,125 underlying) - Tax Payment
Common Stock, $0.0001 par value
2021-12-11$0.64/sh−1,081$686→ 38,571 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Restricted Stock Units vested on December 11, 2021.